- £1.35bn
- £1.28bn
- -$96.90m
- 70
- 70
- 95
- 93
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 8.75 | 6.48 | 126 | 153 | 84.4 |
Net Total Receivables | 0.016 | 0.089 | 0.119 | 0.13 | 0.324 |
Total Current Assets | 8.77 | 6.57 | 126 | 153 | 84.8 |
Long Term Investments | |||||
Total Assets | 226 | 270 | 428 | 1,070 | 1,037 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.384 | 0.392 | 6.98 | 0.97 | 1.93 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.18 | 2.98 | 6.98 | 0.97 | 1.93 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 223 | 267 | 421 | 1,069 | 1,035 |
Total Liabilities & Shareholders' Equity | 226 | 270 | 428 | 1,070 | 1,037 |
Total Common Shares Outstanding |